Basilea Pharmaceutica AG (OTCMKTS:BPMUF – Get Free Report)’s share price gapped up before the market opened on Friday. The stock had previously closed at $65.50, but opened at $76.25. Basilea Pharmaceutica shares last traded at $76.25, with a volume of 10 shares changing hands.
Basilea Pharmaceutica Stock Performance
The stock’s 50 day simple moving average is $72.44 and its 200-day simple moving average is $68.11.
About Basilea Pharmaceutica
Basilea Pharmaceutica Ltd. is a Switzerland-based biopharmaceutical company focused on developing and commercializing medicines for serious bacterial and fungal infections. The company’s portfolio is intended primarily for use in hospitals and other specialized-care settings where drug-resistant pathogens and complex infections present significant treatment challenges.
Basilea’s key products include Cresemba (isavuconazole), an antifungal medicine used to treat invasive aspergillosis and mucormycosis, and Zevtera (ceftobiprole), a cephalosporin antibiotic used for certain serious bacterial infections.
Featured Stories
- Five stocks we like better than Basilea Pharmaceutica
- Time to Nibble on MCD Stock After it Enters Oversold Territory?
- McCormick Stock Trades Cheap, Offers Dividend Growth and Unilever Deal Upside
- Corning and AT&T’s $3 Billion Fiber Deal Reveals Where AI Spending Goes Next
- Target’s Holiday Blitz: Slashing Prices to Capture Market Share
Receive News & Ratings for Basilea Pharmaceutica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Basilea Pharmaceutica and related companies with MarketBeat.com's FREE daily email newsletter.
